Great West Life Assurance CO Halozyme Therapeutics, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 143,802 shares of HALO stock, worth $7.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
143,802
Previous 130,856
9.89%
Holding current value
$7.28 Million
Previous $5.32 Million
41.57%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding HALO
# of Institutions
504Shares Held
125MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$892 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$652 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$294 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$205 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$188 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.05B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...